{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,8]],"date-time":"2025-11-08T22:11:23Z","timestamp":1762639883289},"reference-count":34,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2016,10,1]],"date-time":"2016-10-01T00:00:00Z","timestamp":1475280000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["thegreenjournal.com","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Radiotherapy and Oncology"],"published-print":{"date-parts":[[2016,10]]},"DOI":"10.1016\/j.radonc.2016.07.005","type":"journal-article","created":{"date-parts":[[2016,7,16]],"date-time":"2016-07-16T08:23:17Z","timestamp":1468657397000},"page":"143-147","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Prospective audit showing improved patient-assessed skin toxicity with use of betamethasone cream for those at high risk of radiation dermatitis"],"prefix":"10.1016","volume":"121","author":[{"given":"Sara C.","family":"Erridge","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marie","family":"McCabe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mandy K.","family":"Porter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patricia","family":"Simpson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alison L.","family":"Stillie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.radonc.2016.07.005_b0005","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.ijrobp.2010.05.065","article-title":"Comparison of provider-assessed and patient-reported outcome measures of acute skin toxicity during a Phase III trial of mometasone cream versus placebo during breast radiotherapy: the North Central Cancer Treatment Group (N06C4)","volume":"81","author":"Neben-Wittich","year":"2011","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2016.07.005_b0010","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1111\/j.1365-2133.2011.10390.x","article-title":"Aqueous cream damages the skin barrier","volume":"164","author":"Cork","year":"2011","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.radonc.2016.07.005_b0015","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.radonc.2004.07.032","article-title":"Does aqueous or sucralfate cream affect the severity of erythematous radiation skin reactions? A randomised controlled trial","volume":"73","author":"Wells","year":"2004","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2016.07.005_b0020","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1186\/1471-2407-14-53","article-title":"Prevention and treatment of acute radiation-induced skin reactions: a systematic review and meta-analysis of randomized controlled trials","volume":"14","author":"Chan","year":"2014","journal-title":"BMC Cancer"},{"key":"10.1016\/j.radonc.2016.07.005_b0025","doi-asserted-by":"crossref","first-page":"2933","DOI":"10.1007\/s00520-013-1896-2","article-title":"Clinical practice guidelines for the prevention and treatment of acute and late radiation reactions from the MASCC Skin Toxicity Study Group","volume":"21","author":"Wong","year":"2013","journal-title":"Support Care Cancer"},{"issue":"2","key":"10.1016\/j.radonc.2016.07.005_b0030","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.radonc.2013.05.033","article-title":"A potent steroid cream is superior to emollients in reducing acute radiation dermatitis in breast cancer patients treated with adjuvant radiotherapy. A randomised study of betamethasone versus two moisturizing creams","volume":"108","author":"Ulff","year":"2013","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2016.07.005_b0035","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1016\/j.ijrobp.2014.06.033","article-title":"Mometasone furoate cream reduces acute radiation dermatitis in patients receiving breast radiation therapy: results of a randomized trial","volume":"90","author":"Hindley","year":"2014","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2016.07.005_b0040","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.meddos.2015.09.001","article-title":"Skin dose differences between intensity-modulated radiation therapy and volumetric-modulated arc therapy and between boost and integrated treatment regimens for treating head and neck and other cancer sites in patients","volume":"41","author":"Penoncello","year":"2016","journal-title":"Med Dosim"},{"key":"10.1016\/j.radonc.2016.07.005_b0045","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1016\/j.breast.2013.07.047","article-title":"Smoking as an independent risk factor for severe skin reactions due to adjuvant radiotherapy for breast cancer","volume":"22","author":"Sharp","year":"2013","journal-title":"Breast"},{"key":"10.1016\/j.radonc.2016.07.005_b0050","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1016\/S0360-3016(00)00782-3","article-title":"Randomized phase III study comparing Best Supportive Care to Biafine as a prophylactic agent for radiation-induced skin toxicity for women undergoing breast irradiation: Radiation Therapy Oncology Group (RTOG) 97\u201313","volume":"48","author":"Fisher","year":"2000","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2016.07.005_b0055","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/S0167-8140(01)00327-9","article-title":"Potent corticosteroid cream (mometasone furoate) significantly reduces acute radiation dermatitis: results from a double-blind, randomized study","volume":"59","author":"Bostrom","year":"2001","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2016.07.005_b0060","first-page":"305","article-title":"Topical Biafine and Lipiderm for the prevention of radiation dermatitis: a randomized prospective trial","volume":"8","author":"Fenig","year":"2001","journal-title":"Oncol Rep"},{"key":"10.1016\/j.radonc.2016.07.005_b0065","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1007\/s00066-004-1174-9","article-title":"Theta-Cream versus Bepanthol lotion in breast cancer patients under radiotherapy. A new prophylactic agent in skin care?","volume":"180","author":"Roper","year":"2004","journal-title":"Strahlenther Onkol"},{"key":"10.1016\/j.radonc.2016.07.005_b0070","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1188\/10.ONF.619-626","article-title":"A prospective randomized, placebo-controlled skin care study in women diagnosed with breast cancer undergoing radiation therapy","volume":"37","author":"Gosselin","year":"2010","journal-title":"Oncol Nurs Forum"},{"key":"10.1016\/j.radonc.2016.07.005_b0075","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1007\/s12094-010-0465-0","article-title":"Prophylaxis with a cream containing urea reduces the incidence and severity of radio-induced dermatitis","volume":"12","author":"Pardo Masferrer","year":"2010","journal-title":"Clin Transl Oncol"},{"key":"10.1016\/j.radonc.2016.07.005_b0080","doi-asserted-by":"crossref","first-page":"94","DOI":"10.3747\/co.v17i4.493","article-title":"Prophylaxis and management of acute radiation-induced skin reactions: a systematic review of the literature","volume":"17","author":"Salvo","year":"2010","journal-title":"Curr Oncol"},{"key":"10.1016\/j.radonc.2016.07.005_b0085","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1007\/s00066-011-2204-z","article-title":"Topical use of a silymarin-based preparation to prevent radiodermatitis : results of a prospective study in breast cancer patients","volume":"187","author":"Becker-Schiebe","year":"2011","journal-title":"Strahlenther Onkol"},{"key":"10.1016\/j.radonc.2016.07.005_b0090","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1007\/s00066-011-2224-8","article-title":"Treatment of acute radiodermatitis with an oil-in-water emulsion following radiation therapy for breast cancer: a controlled, randomized trial","volume":"187","author":"Jensen","year":"2011","journal-title":"Strahlenther Onkol"},{"key":"10.1016\/j.radonc.2016.07.005_b0095","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1016\/j.ijrobp.2010.01.031","article-title":"Mometasone furoate effect on acute skin toxicity in breast cancer patients receiving radiotherapy: a phase III double-blind, randomized trial from the North Central Cancer Treatment Group N06C4","volume":"79","author":"Miller","year":"2011","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2016.07.005_b0100","doi-asserted-by":"crossref","first-page":"e305","DOI":"10.1016\/j.ijrobp.2012.03.062","article-title":"Silver clear nylon dressing is effective in preventing radiation-induced dermatitis in patients with lower gastrointestinal cancer: results from a phase III study","volume":"84","author":"Niazi","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2016.07.005_b0105","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1016\/j.ijrobp.2011.09.021","article-title":"Topical hyaluronic acid vs. standard of care for the prevention of radiation dermatitis after adjuvant radiotherapy for breast cancer: single-blind randomized phase III clinical trial","volume":"83","author":"Pinnix","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2016.07.005_b0110","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1186\/1748-717X-8-57","article-title":"Preventing the acute skin side effects in patients treated with radiotherapy for breast cancer: the use of corneometry in order to evaluate the protective effect of moisturizing creams","volume":"8","author":"Di-Franco","year":"2013","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.radonc.2016.07.005_b0115","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.ijrobp.2012.12.009","article-title":"A paired, double-blind, randomized comparison of a moisturizing durable barrier cream to 10% glycerine cream in the prophylactic management of postmastectomy irradiation skin care: trans Tasman Radiation Oncology Group (TROG) 04.01","volume":"86","author":"Graham","year":"2013","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2016.07.005_b0120","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1159\/000353974","article-title":"Prophylaxis of acute radiation dermatitis with an innovative FDA-approved two-step skin care system in a patient with head and neck cancer undergoing a platin-based radiochemotherapy: a case report and review of the literature","volume":"227","author":"Hafner","year":"2013","journal-title":"Dermatology"},{"key":"10.1016\/j.radonc.2016.07.005_b0125","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/j.ejon.2012.11.003","article-title":"No differences between Calendula cream and aqueous cream in the prevention of acute radiation skin reactions\u2013results from a randomised blinded trial","volume":"17","author":"Sharp","year":"2013","journal-title":"Eur J Oncol Nurs"},{"key":"10.1016\/j.radonc.2016.07.005_b0130","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1016\/j.ijrobp.2014.06.034","article-title":"Natural oil-based emulsion containing allantoin versus aqueous cream for managing radiation-induced skin reactions in patients with cancer: a phase 3, double-blind, randomized, controlled trial","volume":"90","author":"Chan","year":"2014","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2016.07.005_b0135","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1186\/1745-6215-15-330","article-title":"Phototherapy 660 nm for the prevention of radiodermatitis in breast cancer patients receiving radiation therapy: study protocol for a randomized controlled trial","volume":"15","author":"Costa","year":"2014","journal-title":"Trials"},{"key":"10.1016\/j.radonc.2016.07.005_b0140","doi-asserted-by":"crossref","first-page":"156","DOI":"10.3857\/roj.2014.32.3.156","article-title":"The safety and efficacy of EGF-based cream for the prevention of radiotherapy-induced skin injury: results from a multicenter observational study","volume":"32","author":"Kang","year":"2014","journal-title":"Radiat Oncol J"},{"key":"10.1016\/j.radonc.2016.07.005_b0145","first-page":"107","article-title":"Topical use of phytotherapic cream (Capilen(R) cream) to prevent radiodermatitis in breast cancer: a prospective historically controlled clinical study","volume":"149","author":"Stefanelli","year":"2014","journal-title":"G Ital Dermatol Venereol"},{"issue":"3","key":"10.1016\/j.radonc.2016.07.005_b0150","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.clbc.2014.12.006","article-title":"Three-arm randomized phase III trial: quality aloe and placebo cream versus powder as skin treatment during breast cancer radiation therapy","volume":"15","author":"Hoopfer","year":"2015","journal-title":"Clin Breast Cancer"},{"key":"10.1016\/j.radonc.2016.07.005_b0155","article-title":"A randomised double blind trial on the use of 1% hydrocortisone cream for the prevention of acute radiation dermatitis","author":"Meghrajani","year":"2015","journal-title":"Expert Rev Clin Pharmacol"},{"key":"10.1016\/j.radonc.2016.07.005_b0160","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1016\/j.ijrobp.2015.02.028","article-title":"Double-blind, placebo-controlled pilot study of processed ultra emu oil versus placebo in the prevention of radiation dermatitis","volume":"92","author":"Rollmann","year":"2015","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2016.07.005_b0165","first-page":"1338","article-title":"Clinical evaluation of safety and efficacy of Boswellia-based cream for prevention of adjuvant radiotherapy skin damage in mammary carcinoma: a randomized placebo controlled trial","volume":"19","author":"Togni","year":"2015","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"10.1016\/j.radonc.2016.07.005_b0170","article-title":"Corticosteroids \u2013 topical (skin), nose, and eyes","author":"NICE","year":"2015"}],"container-title":["Radiotherapy and Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167814016311975?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167814016311975?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,7,3]],"date-time":"2022-07-03T04:56:14Z","timestamp":1656824174000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167814016311975"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,10]]},"references-count":34,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,10]]}},"alternative-id":["S0167814016311975"],"URL":"https:\/\/doi.org\/10.1016\/j.radonc.2016.07.005","relation":{},"ISSN":["0167-8140"],"issn-type":[{"value":"0167-8140","type":"print"}],"subject":[],"published":{"date-parts":[[2016,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prospective audit showing improved patient-assessed skin toxicity with use of betamethasone cream for those at high risk of radiation dermatitis","name":"articletitle","label":"Article Title"},{"value":"Radiotherapy and Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.radonc.2016.07.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Published by Elsevier Ireland Ltd.","name":"copyright","label":"Copyright"}]}}